The significance of carbohydrate 
INTRODUCTION
Pleural effusion -pathological content in the pleural cavity -is a comparatively frequent complication of various diseases. No data of large-scale epidemiological trials are available; however, the number of pleural pathology patients is estimated at 3000 cases per million population a year (Hooper, 2010) . Malignancy is one of the most frequent causes of pleural fluids (Rodriguez-Pandero, 2003) . Upon examination of the pleural puncture fluid the presence of malignant effusion is considered to be proven if malignant cells are detected in cytological examination; however, the mean sensitivity of cytological examination is approximately 60% and depends on sample preparation, the experience of the cytologist and on tumour type (Hooper, 2010) . The most informative method of diagnosing malignant pleural effusion is diagnostic thoracoscopy, which enables collection of pathologically altered tissue samples under visual control and proving the diagnosis histological; however, in practice faster, cheaper, and less invasive procedures are often required for the specification of the patient's diagnosis. Thus, new markers that are sufficiently sensitive to prove the probability of malignancy are being sought.
Cancer antigen Ca-125 is a high molecular mass protein, which is produced by epithelial ovary cancers and mesothelial cells. Ca-125 is most frequently used to monitor the results of ovarian cancer therapy; however, Ca-125 can be elevated in the event of both malignant and benign pathologies, probably because of the involvement of serous membranes and the irritation of mesothelial cells (Miralles, 2003; How et al., 2006) . The mechanism of this process is not fully known yet. Levels of Ca-125 are most frequently estimated in blood serum, while the levels in serous cavity fluids tend to be more informative (Korczynski, 2009) .
CEA (carcinoembryonic antigen) is a glycoprotein involved in cell adhesion, which is produced during the embryonic development. The synthesis of CEA ceases upon birth; however, elevated levels of CEA are observed detected in patients with colorectal, pancreatic, lung and breast cancer, in smokers, cirrhosis patients, as well as in certain other cases. Although CEA is not a specific indicator, the level of CEA can increase 4-8 times before the clinical symptoms caused by a tumour develop (Nicholson et al., 2014) .
PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B, Vol. 70 (2016) The goals of the research were:
1. To determine the Ca-125 and CEA levels in serum and pleural effusion, as well as Ca-125 and CEA effusion/serum ratios in patients with pleural effusion; 2. To compare the Ca-125 and CEA levels in patients with malignant pleural effusion and those with pleural effusions of different aetiology; 3. To establish diagnostic validity of tumour markers Ca-125 and CEA in differential diagnosis of pleural effusion.
MATERIALS AND METHODS
The research protocol was confirmed by the Ethics Committee of Rîga Stradiòð University. An approved informed consent form was signed from all subjects.
In the period from 1 August 2008 to 22 April 2013, 121 patients consecutively admitted at the 2 nd Pulmonology Department, Gaiïezers Clinic of Rîga East Clinical University Hospital, with radiological and ultrasound findings of fluid in the pleural cavity, were included in the study. All patients included in the study were subject to pleural puncture in accordance with clinical indications. Light's criteria (Light et al., 1972) for the differentiation between exudative effusion and transudative effusion were determined and clinical and cytological analysis of pleural fluid sample was performed.
Patients in whom clinical analysis revealed the count of monomorphonuclear cells to be > 95%, were subject to blind pleural biopsy, which involves collection of core biopsy samples through the chest wall for histological examination. Venous blood samples and pleural effusion samples were collected from each patient in an EDTA vacutainer, centrifuged for 10 minutes at 3000 rpm to obtain plasma samples and stored at -80 o C until assayed. Ca-125 and CEA were measured with ELISA using an Abbott Architect device according to the manfacturer's protocol. In order to draw conclusions on the clinical significance of the markers, the sensitivity and specificity of both marker levels in serum and punctate as well as the proportion of markers in punctate/serum were calculated. Receiver operating characteristic (ROC) curves and area under the curve (AUC) analysis were estimated. Pleural fluid was considered to be malignant if malignant cells were found in the pleural fluid, or if the patient had had a previously confirmed malignant disease and no other cause for the presence of pleural fluid was found (Sahn, 1997) . Diagnosis of tuberculous pleurisy was confirmed by finding specific changes -tuberculous granulomas during the histological examination of the pleural fluid. Parapneumonic pleurisy or pleural empyema was diagnosed in patients with acute onset of the disease, febrile temperature, chest pain, infiltrates in chest X-Ray examination or computed tomography scans and positive bacterial culture in pleural cavity, in case other causes were excluded. Transudative effusion was diagnosed in cardiac failure patients based on signs of cardiac failure (peripheral oedema, history of known cardiac disease, echocardiogramm signs of cardiac failure or venous congestion in the chest X-ray). Elevated lipase level in the pleural fluid was used to diagnose pleurisy associated with pancreatitis.
Statistical analysis. Microsoft Excel and online software for the Chi-squared c 2 test with calculation of significant differences (Preacher, 2001) were used for data processing, as well as teh VassarStats online computer programme for calculation of test sensitivity and specificity (Lowry, 1998 (Lowry, -2012 . In accordance with generally accepted principles in medical statistics, a p value of 0.05 was considered to be the statistical significance threshold.
The arithmetic mean and standard deviation was used for the description of quantitative variables; however, if the data distribution did not conform to the norm, we used median and quartiles Q 1 and Q 3 , as well as the range (minimum and maximum values). The conformity of data to the norm was checked using a Kolmogorov-Smirnov test and histograms.
The Chi-squared c 2 test was used for the comparison of categorical variables in different groups.
RESULTS
The presence of fluid in the pleural cavity was found in 121 patients from 30 to 90 years of age; 62 (57%) of the patients were male. Malignant pleural effusion was detected in 55 patients, parapneumonic effusion in 28 patients, transudative effusion of cardiac origin in 31 patients, pancreatitis in 1 patient, and tuberculous pleurisy in 5 patients (Table 1 ).
In the group of malignant pleurisies, 11 patients had breast cancer, 11 patients ovarian cancer, 19 patients lung cancer, 2 patients renal cancer, 2 patients cervical cancer, 2 gastric cancer, 1 patient pancreatic cancer, 1 sarcoma, 1 pleural mesothelioma, and unknown primary cancer in 5 patients ( Table 2 ). The sensitivity of cytological examination was 71%, specifity -100%.
In order to determine whether statistically significant differences between Ca-125 and CEA in the pleural fluid of different aetiology exist, the groups of parapneumonic pleu- risy, malignant pleural effusion and transudative effusion were subject to further analysis. Median serum and pleural fluid levels of Ca-125 and CEA were determined in all three groups (Table 3) . Tuberculous pleurisy and pleurisy due to pancreatitis were not included in further analysis due to the small number of patients.
In almost all cases (except Ca-125 effusion/serum ratio) the highest accuracy was found when the cut-off or differentiation of malignant effusion was set based on the 3 rd quartile rather than 1 st or 2 nd (Table 4 ). The accuracy ranged from 64% to 77% for CEA marker and from 58% to 75% for Ca-125. Similarly, the sensitivity was also highest for cut-offs based on the 75 th percentile, while the specificity was best at the 25 th percentile. Thus, the highest accuracy was found for Ca-125 effusion of ³1452 U/ml (75.2%) and for CEA effusion of ³6.58 mg/ml (76.9%). Area under curves was also highest in CA-125 in pleural effusion and CEA in pleural effusion, 0.793 and 0.761, respectively (Table 5, Figure 1 ).
DISCUSSION
In order to establish the probable significance of the Ca-125 tumour marker in differential diagnosis of pleurisy, 121 patients with fluid in the pleural cavity were examined.
It was found that higher accuracy and sensitivity either for Ca-125 or CEA levels were found when the 75 th percentile was used as the cut-off value, while the highest specificity was found using the 25 th percentile as the cut-off value. The highest positive predictive value was established for Ca-125 and CEA concentration in the pleural fluid, in contrast to the concentration of these markers in the serum or ratios of fluid/serum concentration. Thus, concentrations in pleural fluid allow to make conclusions on its local production in both impaired mesothelial cells (Ca-125) and malignant cells. A high pleural puncture fluid/serum ratio of Ca-125 for malignant effusion in comparison with the fluid of other origin in the pleural cavity can indicate limited systemic diffusion. Ma et al. (2013) retrospectively determined the level of Ca-125 in blood serum in 2115 patients with chronic cardiac failure aged over 85 and found that the Ca-125 level in blood serum was significantly elevated in patients with fluid in the pleural cavity and peripheral oedema. DurakNalbantic et al. (2013) measured Ca-125 in the serum of 76 patients with cardiac failure and came to the same conclusion: serum Ca-125 level was higher in patients with fluid in the pleural and pericardial cavities. Turk et al. (2003) , compared cardiac failure patients with and without transudate in pleural cavity and healthy volunteers, and also found that the Ca-125 level was significantly higher in patients with cardiac failure and transudative effusion in pleural cavity. In our study we did not find a signicant difference in Ca-125 level in patients with cardiac failure and transudative effusion in the pleural cavity and in patients with malignant pleural effusion (p < 0.139); however, the difference in levels in the pleural fluid did significantly differ (p < 0.001). Choi et al. (2013) determined Ca-125 levels in pleural puncture fluid of 326 patients and afterwards retrospectively analysed its level in patients with various aetiology of the pleural fluid. It was concluded that significant elevation of Ca-125 occurred in patients with pleural fluid of malignant origin (more than 1/3 of the patients had Ca-125 levels of >600 U/ml), but the difference was statistically insignificant in patients with transudative effusion and fluid of benign aetiology in the pleural cavity. No significant differences in Ca-125 levels were detected for patients with cancer of different localisation as well, which leads to the conclusion that the impairment of mesothelial cells does not depend on the type of cancer. According to our calculations, the medial level of Ca-125 in malignant pleural effusion was 1452 U/ml and the difference in its level in the event of malignant effusions from either transudative effusion or parapneu- monic pleurisy cases was statistically significant (p < 0.001). Kalantri et al. (2007) analysed non-specific elevation of Ca-125 in 38 patients with pleural fluid and 46 patients with ascites (including either exudative effusion or transudative effusion). It was found that the elevation of Ca-125 was statistically significant in patients with ascites of any aetiology, which allowed to conclude that mesothelial cells of the abdominal cavity have a higher capacity for producing this substance. Bielsa et al. (2009) determined various tumour markers, including CEA and Ca-125, in 224 patients with confirmed malignant pleural effusion in the pleural fluid. They found that a level of Ca-125 above 1000 U/ml in combination with fragments of cytokeratin 19 -CYFRA 21-1 of >100 ng/ml was significantly associated with lower survival (Bielsa et al., 2009) . Xu et al. (2015) determined the level of CEA in 60 malignant and 58 benign pleural fluids and established that in 54 patients with malignant pleural effusion the level of CEA was >5.5 ng/ml and at this cut-off value the combination of CEA with tumour marker Type II membran protein RCAS yielded sensitivity of 98.3 and specificity of 91.4% (Xu et al., 2015) ; according to our data, at a cut-off value of 6.58 ng/ml the sensitivity of CEA was 58.2% and specificity 92.4%. Son et al. (2015) analysed 47 benign and 52 malignant pleural effusions and compared the diagnostic values of tumour markers CD66c, CEA, Ca 19-9, and CYFRA 21-1 in pleural puncture fluid. They found that CEA has the highest diagnostic value with sensitivity of 87.2% and specificity of 92.3% (Son et al., 2015) . The sensitivity was considerably lower in our data, while specificity was similar -92.4%.
CONCLUSIONS
The analysis of our data and that of several authors indicate that:
1. In cases of malignant effusion the level of Ca-125 and CEA are significantly higher in pleural fluid.
2. The relatively high accuracy of Ca-125 and CEA, upon determining them in pleural fluid, allows use of these markers as additional diagnostic criteria for the determination of malignancy; however, neither the Ca-125 and CEA level in serum, nor puncture fluid/serum ratio have considerable diagnostic significance.
